Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Apr;108(4):1055–1061. doi: 10.1111/j.1476-5381.1993.tb13505.x

Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats.

S M Yu 1, Y F Kang 1, C C Chen 1, C M Teng 1
PMCID: PMC1908156  PMID: 8485617

Abstract

1. The effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity were investigated in Wistar-Kyoto (WKY) and spontaneously hypertensive (SH) rats, fed a high fat-high cholesterol diet. 2. In high fat-high cholesterol (HF-HC) diet fed WKY and SH rats, oral administration of dicentrine (5 and 10 mg kg-1, twice a day) for 4 weeks caused significant reductions in total plasma cholesterol (CE) by reducing the low density lipoprotein (LDL) fraction, and reductions in total plasma triglyceride (TG) by reducing the very low density lipoprotein (VLDL) fraction. 3. Dicentrine therapy was associated with increased high density lipoprotein (HDL)-cholesterol levels; thus the ratio of total plasma cholesterol to HDL-cholesterol was improved. 4. In HF-HC diet fed conscious WKY and SH rats, oral administration of dicentrine (5 and 10 mg kg-1, twice a day) also evoked dose-related decreases in mean arterial pressure (MAP) which were of greater magnitude in SH rats. Neither dose of dicentrine caused a significant change in heart rate (HR). 5. The aortic arches from SH rats fed the HF-HC diet for 8 weeks were significantly more affected by the atherosclerotic lesions than the abdominal aortae and renal arteries of WKY and SH rats. Oral administration of dicentrine (5 and 10 mg kg-1) for 4 weeks did not diminish the atherosclerotic lesion areas in WKY and SH rats. 6. In aortae of the hyperlipidaemic rats, significantly attenuated EC50 values and augmented maximal responses for phenylephrine-induced contraction were obtained. Endothelium-dependent relaxation to acetylcholine was abolished, while endothelium-independent relaxation to nitroprusside was well preserved.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castelli W. P., Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986 Feb 14;80(2A):23–32. doi: 10.1016/0002-9343(86)90157-9. [DOI] [PubMed] [Google Scholar]
  2. Chen C. C., Huang Y. L., Ou J. C., Su M. J., Yu S. M., Teng C. M. Bioactive principles from the roots of Lindera megaphylla. Planta Med. 1991 Oct;57(5):406–408. doi: 10.1055/s-2006-960135. [DOI] [PubMed] [Google Scholar]
  3. Chobanian A. V. The influence of hypertension and other hemodynamic factors in atherogenesis. Prog Cardiovasc Dis. 1983 Nov-Dec;26(3):177–196. doi: 10.1016/0033-0620(83)90005-1. [DOI] [PubMed] [Google Scholar]
  4. Chong K. S., Nicolosi R. J., Rodger R. F., Arrigo D. A., Yuan R. W., MacKey J. J., Georas S., Herbert P. N. Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey. J Clin Invest. 1987 Mar;79(3):675–683. doi: 10.1172/JCI112870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dall'Aglio E., Chang H., Reaven G. Disparate effects of prazosin and propranolol on lipid metabolism in a rat model. Metabolism. 1983 May;32(5):510–513. doi: 10.1016/0026-0495(83)90015-x. [DOI] [PubMed] [Google Scholar]
  6. DeLamatre J. G., Roheim P. S. Effect of cholesterol feeding on apo B and apo E concentrations and distributions in euthyroid and hypothyroid rats. J Lipid Res. 1981 Feb;22(2):297–306. [PubMed] [Google Scholar]
  7. Demacker P. N., van Sommeren-Zondag D. F., Stalenhoef A. F., Stuyt P. M., van't Laar A. Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3. Clin Chem. 1983 Apr;29(4):656–663. [PubMed] [Google Scholar]
  8. Heistad D. D., Armstrong M. L., Marcus M. L., Piegors D. J., Mark A. L. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984 Jun;54(6):711–718. doi: 10.1161/01.res.54.6.711. [DOI] [PubMed] [Google Scholar]
  9. Hirata K., Akita H., Yokoyama M., Watanabe Y. Impaired vasodilatory response to atrial natriuretic peptide during atherosclerosis progression. Arterioscler Thromb. 1992 Jan;12(1):99–105. doi: 10.1161/01.atv.12.1.99. [DOI] [PubMed] [Google Scholar]
  10. Kolodgie F. D., Virmani R., Rice H. E., Mergner W. J. Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits. Circ Res. 1990 Apr;66(4):1112–1126. doi: 10.1161/01.res.66.4.1112. [DOI] [PubMed] [Google Scholar]
  11. Krause B. R., Newton R. S. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats. J Lipid Res. 1985 Aug;26(8):940–949. [PubMed] [Google Scholar]
  12. Krzesinski J. M., Carlier P. G., Rorive G. L. Interrelationship of hypertension, plasma lipids and atherosclerosis. Drugs. 1988;36 (Suppl 2):18–26. doi: 10.2165/00003495-198800362-00005. [DOI] [PubMed] [Google Scholar]
  13. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  14. Miller N. E. Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations. Am J Cardiol. 1987 Sep 18;60(9):17E–23E. doi: 10.1016/0002-9149(87)90537-6. [DOI] [PubMed] [Google Scholar]
  15. Roeschlau P., Bernt E., Gruber W. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem. 1974 May;12(5):226–226. [PubMed] [Google Scholar]
  16. Rosendorff C., Hoffman J. I., Verrier E. D., Rouleau J., Boerboom L. E. Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res. 1981 Mar;48(3):320–329. doi: 10.1161/01.res.48.3.320. [DOI] [PubMed] [Google Scholar]
  17. Takayama M., Itoh S., Nagasaki T., Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta. 1977 Aug 15;79(1):93–98. doi: 10.1016/0009-8981(77)90465-x. [DOI] [PubMed] [Google Scholar]
  18. Teng C. M., Yu S. M., Ko F. N., Chen C. C., Huang Y. L., Huang T. F. Dicentrine, a natural vascular alpha 1-adrenoceptor antagonist, isolated from Lindera megaphylla. Br J Pharmacol. 1991 Nov;104(3):651–656. doi: 10.1111/j.1476-5381.1991.tb12484.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Uchida K., Nomura Y., Kadowaki M., Takase H., Takeuchi N. Disturbance of cholesterol and bile acid metabolism in spontaneously hypertensive rats (SHR). J Biochem. 1978 Nov;84(5):1113–1118. doi: 10.1093/oxfordjournals.jbchem.a132225. [DOI] [PubMed] [Google Scholar]
  20. Weinberger M. H. Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. Am J Med. 1986 Feb 14;80(2A):64–70. doi: 10.1016/0002-9343(86)90162-2. [DOI] [PubMed] [Google Scholar]
  21. Yu S. M., Hsu S. Y., Ko F. N., Chen C. C., Huang Y. L., Huang T. F., Teng C. M. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol. 1992 Aug;106(4):797–801. doi: 10.1111/j.1476-5381.1992.tb14415.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES